Abstract
One of the aims of transplantation is to restore the potential for a full life to individuals with ESRD. To obtain this strategies that allow better and longer allograft function and a reduction in adverse events that lead to premature death are required. To this end, the recommendations below showed reduce cardiovascular disease and help present and future transplant recipients live a full life. Focusing on traditional risk factors (hypertension, hyperlipidemia, discontinuation of smoking, and prevention and treatment of diabetes mellitus) in patients at risk and striving for the recommended targets will have the greatest clinical benefit. These strategies should begin in the pre-dialysis and dialysis phases in order to reduce the cumulative burden of disease. Failing this, early and hopefully pre-emptive transplantation should be the goal.
MeSH terms
-
Arteriosclerosis / epidemiology
-
Arteriosclerosis / therapy
-
Aspirin / therapeutic use
-
Cardiovascular Agents / therapeutic use
-
Cardiovascular Diseases / epidemiology
-
Cardiovascular Diseases / etiology
-
Cardiovascular Diseases / prevention & control*
-
Comorbidity
-
Cost-Benefit Analysis
-
Diabetes Mellitus / drug therapy
-
Diabetes Mellitus / epidemiology
-
Diabetes Mellitus / surgery
-
Heart Function Tests
-
Humans
-
Hyperlipidemias / drug therapy
-
Hyperlipidemias / epidemiology
-
Hypertension / drug therapy
-
Hypertension / epidemiology
-
Hypertrophy, Left Ventricular / epidemiology
-
Hypertrophy, Left Ventricular / therapy
-
Hypoglycemic Agents / therapeutic use
-
Hypolipidemic Agents / therapeutic use
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use
-
Kidney Failure, Chronic / epidemiology
-
Kidney Failure, Chronic / surgery*
-
Kidney Failure, Chronic / therapy
-
Kidney Transplantation*
-
Life Expectancy
-
Pancreas Transplantation
-
Postoperative Complications / epidemiology
-
Postoperative Complications / etiology
-
Postoperative Complications / prevention & control*
-
Prevalence
-
Renal Dialysis
-
Risk Reduction Behavior
-
Smoking Cessation
-
Treatment Outcome
Substances
-
Cardiovascular Agents
-
Hypoglycemic Agents
-
Hypolipidemic Agents
-
Immunosuppressive Agents
-
Aspirin